Insider Selling: Astera Labs (NASDAQ:ALAB) Director Sells 10,000 Shares of Stock

Astera Labs, Inc. (NASDAQ:ALABGet Free Report) Director Jack Lazar sold 10,000 shares of the company’s stock in a transaction that occurred on Thursday, June 4th. The shares were sold at an average price of $355.17, for a total value of $3,551,700.00. Following the transaction, the director owned 75,688 shares of the company’s stock, valued at approximately $26,882,106.96. This represents a 11.67% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Astera Labs Stock Performance

Shares of Astera Labs stock traded up $29.27 during midday trading on Monday, reaching $346.33. 5,034,882 shares of the company’s stock traded hands, compared to its average volume of 5,971,726. The company has a market cap of $59.36 billion, a PE ratio of 234.01, a price-to-earnings-growth ratio of 4.20 and a beta of 3.94. The stock has a 50 day moving average of $217.60 and a 200-day moving average of $173.27. Astera Labs, Inc. has a 12 month low of $84.78 and a 12 month high of $372.37.

Astera Labs (NASDAQ:ALABGet Free Report) last announced its earnings results on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, beating analysts’ consensus estimates of $0.54 by $0.07. The company had revenue of $308.36 million during the quarter, compared to the consensus estimate of $292.19 million. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The firm’s revenue for the quarter was up 93.5% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.33 earnings per share. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, equities analysts anticipate that Astera Labs, Inc. will post 1.84 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Astera Labs

Institutional investors have recently modified their holdings of the stock. Assetmark Inc. grew its stake in shares of Astera Labs by 374.1% in the third quarter. Assetmark Inc. now owns 128 shares of the company’s stock worth $25,000 after acquiring an additional 101 shares during the last quarter. Reflection Asset Management purchased a new stake in shares of Astera Labs in the fourth quarter worth $25,000. Smartleaf Asset Management LLC grew its stake in shares of Astera Labs by 422.2% in the fourth quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock worth $32,000 after acquiring an additional 152 shares during the last quarter. Hilltop National Bank grew its stake in shares of Astera Labs by 100.0% in the fourth quarter. Hilltop National Bank now owns 200 shares of the company’s stock worth $33,000 after acquiring an additional 100 shares during the last quarter. Finally, Aventura Private Wealth LLC purchased a new stake in shares of Astera Labs in the fourth quarter worth $33,000. 60.47% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on ALAB shares. JPMorgan Chase & Co. increased their price objective on Astera Labs from $205.00 to $280.00 and gave the stock an “overweight” rating in a report on Wednesday, May 6th. Susquehanna increased their price objective on Astera Labs from $155.00 to $230.00 and gave the stock a “neutral” rating in a report on Wednesday, May 6th. TD Cowen increased their price objective on Astera Labs from $140.00 to $225.00 and gave the stock a “hold” rating in a report on Wednesday, May 6th. Weiss Ratings upgraded Astera Labs from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, May 21st. Finally, Northland Securities downgraded Astera Labs from an “outperform” rating to a “market perform” rating in a report on Tuesday, May 26th. Twelve equities research analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $233.75.

View Our Latest Stock Report on ALAB

Astera Labs Company Profile

(Get Free Report)

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

Read More

Insider Buying and Selling by Quarter for Astera Labs (NASDAQ:ALAB)

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.